000 03864nam a22005535i 4500
001 978-3-540-26420-0
003 DE-He213
005 20161121230558.0
007 cr nn 008mamaa
008 100301s2005 gw | s |||| 0|eng d
020 _a9783540264200
_9978-3-540-26420-0
024 7 _a10.1007/b137553
_2doi
050 4 _aR895-920
072 7 _aMMPH
_2bicssc
072 7 _aMMP
_2bicssc
072 7 _aMED008000
_2bisacsh
082 0 4 _a616.0757
_223
245 1 0 _aDynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology
_h[electronic resource] /
_cedited by Alan Jackson, David L. Buckley, Geoffrey J. M. Parker.
246 3 _aWith contribution by numerous experts
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2005.
300 _aXII, 311 p. 295 illus., 85 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aMedical Radiology, Diagnostic Imaging,
_x0942-5373
505 0 _aPrinciples of Dynamic Contrast-Enhanced MRI -- An Introduction to Dynamic Contrast-Enhanced MRI in Oncology -- Contrast Agents for Magnetic Resonance Imaging -- The Role of Blood Pool Contrast Media in the Study of Tumor Pathophysiology -- Quantification of Dynamic Susceptibility Contrast T2* MRI in Oncology -- Measuring Contrast Agent Concentration in T1-Weighted Dynamic Contrast-Enhanced MRI -- Tracer Kinetic Modelling for T1-Weighted DCE-MRI -- Imaging Techniques -- Imaging Techniques for Dynamic Susceptibility Contrast-Enhanced MRI -- Consensus Recommendations for Acquisition of Dynamic Contrasted-Enhanced MRI Data in Oncology -- Clinical Applications -- Dynamic Contrast-Enhanced MRI in Cerebral Tumours -- Dynamic Magnetic Resonance Imaging in Breast Cancer -- Dynamic Contrast-Enhanced MR Imaging for Predicting Tumor Control in Patients with Cervical Cancer -- Dynamic Contrast-Enhanced MRI of Prostate Cancer -- Dynamic Contrast-Enhanced MR Imaging in Musculoskeletal Tumors -- Dynamic Contrast-Enhanced MRI in the Liver -- Applications -- Use of Dynamic Contrast-Enhanced MRI in Multi-Centre Trials with Particular Reference to Breast Cancer Screening in Women at Genetic Risk -- Applications of Dynamic Contrast-Enhanced MRI in Oncology Drug Development.
520 _aDynamic contrast-enhanced MRI is now established as the methodology of choice for the assessment of tumor microcirculation in vivo. This is assisting clinical practitioners in the management of patients with solid tumors and is finding prominence in the assessment of tumor treatments, including anti-angiogenics, chemotherapy, and radiotherapy. In this book, targeted at both clinical practitioners and basic scientists, the principles of the methods, their practical implementation, and their application to specific tumor types are discussed by the leading authorities in the field today. The book will serve as an invaluable single-volume reference covering all the latest developments in contrast-enhanced oncological MRI.
650 0 _aMedicine.
650 0 _aRadiology.
650 0 _aOncology.
650 0 _aBiophysics.
650 0 _aBiological physics.
650 1 4 _aMedicine & Public Health.
650 2 4 _aImaging / Radiology.
650 2 4 _aDiagnostic Radiology.
650 2 4 _aOncology.
650 2 4 _aBiophysics and Biological Physics.
700 1 _aJackson, Alan.
_eeditor.
700 1 _aBuckley, David L.
_eeditor.
700 1 _aParker, Geoffrey J. M.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783540423225
830 0 _aMedical Radiology, Diagnostic Imaging,
_x0942-5373
856 4 0 _uhttp://dx.doi.org/10.1007/b137553
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c500841
_d500841